Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Aktivax
AddedFeb 18, 2024
UpdatedJun 18, 2026
Aktivax

Aktivax

Angel

Aktivax innovates drug delivery tech for emergencies, offering robust auto-injectors with extended shelf life.

HQ
Aurora, CO, US
Founded
2008
Overview
Compare
Fundraising
Employees
Website

Aktivax, founded with a mission to revolutionize emergency drug delivery, focuses on developing advanced drug delivery technologies. Its flagship product, the ARAI auto-injector, is designed for simplicity and robustness, offering improved drug stability and extended shelf life. The company targets emergency medical treatments, aiming to enhance the reliability and effectiveness of life-saving interventions.

Notable figures affiliated with Aktivax include experts in pharmaceutical development and emergency medicine. The company has attracted significant investment from leading venture capital firms specializing in healthcare innovation. Key achievements include the successful development and deployment of the ARAI auto-injector, which has set new standards in the industry for drug stability and usability. Aktivax's impact is evident in its contribution to improving emergency medical responses and patient outcomes.

Aktivax - Similar Companies

Akttyva Therapeutics logo

Akttyva Therapeutics

akttyva.com

AdrenaCard logo

AdrenaCard

adrenacard.com

Ativa Medical logo

Ativa Medical

ARS Pharmaceuticals logo

ARS Pharmaceuticals

ars-pharma.com

Avive Solutions logo

Avive Solutions

avive.life

AerovectRx logo

AerovectRx

Enable Injections logo

Enable Injections

Ezra Innovations logo

Ezra Innovations

ezrapharma.com

ApiJect Systems logo

ApiJect Systems

apiject.com

RxActuator logo

RxActuator

Qnovia logo

Qnovia

qnovia.com

Aristea Therapeutics logo

Aristea Therapeutics

Solution Medical logo

Solution Medical

Active Life Scientific logo

Active Life Scientific

Genixus logo

Genixus

Aktivax - Quick Facts

Who are Aktivax's competitors?

Companies similar to Aktivax include Akttyva Therapeutics, AdrenaCard, Ativa Medical and ARS Pharmaceuticals.

When was Aktivax founded?

Aktivax was founded in 2008.

Where is Aktivax's headquarters located?

Aktivax's headquarters is located in Aurora, CO, US.

When was Aktivax's last funding round?

Aktivax's most recent funding round was for $100k (USD) in March 2012.

How much has Aktivax raised to-date?

As of Mar 21, 2012, Aktivax has raised a total of $515.3k (USD).

How many employees does Aktivax have?

Aktivax has 7 employees as of Feb 5, 2024.

Aktivax - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Transactional
Customer
  • Enterprise
  • Government
Main Product
  • Drug Delivery
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 8 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research